Probenecid
CAS No. 57-66-9
Probenecid( NSC 18786 )
Catalog No. M15105 CAS No. 57-66-9
The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 46 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 34 | In Stock |
|
| 1G | 47 | In Stock |
|
Biological Information
-
Product NameProbenecid
-
NoteResearch use only, not for human use.
-
Brief DescriptionThe prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate.
-
DescriptionThe prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC 18786
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorTRPV2
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number57-66-9
-
Formula Weight285.36
-
Molecular FormulaC13H19NO4S
-
Purity>98% (HPLC)
-
SolubilityEthanol: 22 mg/mL (77.09 mM); DMSO: 57 mg/mL (199.74 mM)
-
SMILESCCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
-
Chemical Name4-(dipropylsulfamoyl)benzoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.McDonough PM, et al. Cell Calcium, 1989, 10(3), 171-180.
molnova catalog
related products
-
Pyr3
Pyr3 is a selective transient receptor potential canonical channel 3 inhibitor. Pyr3 inhibits TRPC3-mediated Ca2+ influx in a dose-dependent manner(IC50 = 700 nM).
-
TC-I2000
TC-I2000 is an TRPM8 channel blocker. Inhibits?icilin-induced TRPM8 channel activation in rTRPM8-expressing CHO cells with IC50?of 53 nM.
-
Pinokalant
Pinokalant (LOE-908) is a novel non-selective cation channel inhibitor.Pinokalant significantly reduces cortical infarct volume in in vivo experiments, improves the metabolic and electrophysiological status of the ischemic penumbra region.
Cart
sales@molnova.com